耗材描述

NNZ 2591 是环状甘氨酸脯氨酸 (cGP) 小肽的合成类似物。NNZ 2591 具有口服活性并能穿过血脑屏障。NNZ 2591 在缺血性脑损伤后显示出神经保护作用。NNZ 2591 改善帕金森病大鼠模型的运动功能。NNZ 2591 具有研究缺血性脑损伤和天使综合征的潜力。更多产品详情查看：www.medchemexpress.cn/nnz-2591.html

猜你喜欢

• 

  SYT17 Human Pre-designed siRNA Set A | MedChemExpress (MCE)

• 

  SYT15 Human Pre-designed siRNA Set A | MedChemExpress (MCE)

• 

  SYT14 Human Pre-designed siRNA Set A | MedChemExpress (MCE)

• 

  SYT13 Human Pre-designed siRNA Set A | MedChemExpress (MCE)

• 

  SYT12 Human Pre-designed siRNA Set A | MedChemExpress (MCE)

• 

  SYT11 Human Pre-designed siRNA Set A | MedChemExpress (MCE)

• 

  SYT10 Human Pre-designed siRNA Set A | MedChemExpress (MCE)

• 

  SYT1 Human Pre-designed siRNA Set A | MedChemExpress (MCE)

• 

  SYS1 Human Pre-designed siRNA Set A | MedChemExpress (MCE)

• 

  SYPL2 Human Pre-designed siRNA Set A | MedChemExpress (MCE)

AI问答

• NNZ 2591 | MedChemExpress (MCE)配套的仪器设备？
• NNZ 2591 | MedChemExpress (MCE)可以搭配的相关耗材试剂？
• NNZ 2591 | MedChemExpress (MCE)的详细规格参数是什么？
• NNZ 2591 | MedChemExpress (MCE)的使用的注意事项？

感兴趣产品

• NNZ 2591 | MedChemExpress (MCE)价格
• NNZ 2591 | MedChemExpress (MCE)厂商
• NNZ 2591 | MedChemExpress (MCE)规格